These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9257774)

  • 1. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds.
    Del Poeta M; Schell WA; Perfect JR
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1835-6. PubMed ID: 9257774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.
    Espinel-Ingroff A
    J Clin Microbiol; 1998 Oct; 36(10):2950-6. PubMed ID: 9738049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.
    Pfaller MA; Marco F; Messer SA; Jones RN
    Diagn Microbiol Infect Dis; 1998 Apr; 30(4):251-5. PubMed ID: 9582584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of FK463, a novel lipopeptide antifungal agent, against a variety of clinically important molds.
    Nakai T; Uno J; Otomo K; Ikeda F; Tawara S; Goto T; Nishimura K; Miyaji M
    Chemotherapy; 2002 May; 48(2):78-81. PubMed ID: 12011539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: inhibition of glucan synthase and reduction of beta-D-1,3 glucan levels in culture.
    Kahn JN; Hsu MJ; Racine F; Giacobbe R; Motyl M
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2214-6. PubMed ID: 16723587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
    Espinel-Ingroff A; Arthington-Skaggs B; Iqbal N; Ellis D; Pfaller MA; Messer S; Rinaldi M; Fothergill A; Gibbs DL; Wang A
    J Clin Microbiol; 2007 Jun; 45(6):1811-20. PubMed ID: 17428932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspofungin: an echinocandin antifungal agent.
    Stone EA; Fung HB; Kirschenbaum HL
    Clin Ther; 2002 Mar; 24(3):351-77; discussion 329. PubMed ID: 11952021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species.
    Vazquez JA; Lynch M; Boikov D; Sobel JD
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1612-4. PubMed ID: 9210698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.
    Arikan S; Lozano-Chiu M; Paetznick V; Rex JH
    Antimicrob Agents Chemother; 2001 Jan; 45(1):327-30. PubMed ID: 11120990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
    Arikan S; Lozano-Chiu M; Paetznick V; Rex JH
    Antimicrob Agents Chemother; 2002 Jan; 46(1):245-7. PubMed ID: 11751145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K; Tredup A; Salvenmoser S; Müller FM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
    Espinel-Ingroff A
    Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory evaluation of new antifungal agents against rare and refractory mycoses.
    Sutton DA
    Curr Opin Infect Dis; 2002 Dec; 15(6):575-82. PubMed ID: 12821833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro.
    Franzot SP; Casadevall A
    Antimicrob Agents Chemother; 1997 Feb; 41(2):331-6. PubMed ID: 9021188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds.
    Espinel-Ingroff A; Fothergill A; Ghannoum M; Manavathu E; Ostrosky-Zeichner L; Pfaller MA; Rinaldi MG; Schell W; Walsh TJ
    J Clin Microbiol; 2007 Jul; 45(7):2180-2. PubMed ID: 17475760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of anidulafungin against selected clinically important mold isolates.
    Odabasi Z; Paetznick VL; Rodriguez JR; Chen E; Ostrosky-Zeichner L
    Antimicrob Agents Chemother; 2004 May; 48(5):1912-5. PubMed ID: 15105159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of MICs of aminocandin for Candida spp. and filamentous fungi.
    Isham N; Ghannoum MA
    J Clin Microbiol; 2006 Dec; 44(12):4342-4. PubMed ID: 17021057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates.
    Lamoth F; Alexander BD
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4308-11. PubMed ID: 25896696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of Syn-2869, a novel triazole agent, against emerging and less common mold pathogens.
    Johnson EM; Szekely A; Warnock DW
    Antimicrob Agents Chemother; 1999 May; 43(5):1260-3. PubMed ID: 10223947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.